Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TYMP | P19971 | 4/20 | 0.40 |
| ▸ | TK1 | P04183 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8910349 | 0.84 | MAPK1 (0.41) | MAPK1HPGDTYMPTK1 | |
| SCHEMBL13724687 | 0.81 | MAPK1 (0.43) | MAPK1HPGDTYMPTK1 | |
| SCHEMBL27744847 | 0.81 | LMNA (0.46) | — | |
| SCHEMBL28402505 | 0.80 | TK1 (0.39) | MAPK1HPGDTYMPTK1 | |
| SCHEMBL28483586 | 0.79 | LMNA (0.44) | — | |
| SCHEMBL8412383 | 0.79 | TYMP (0.43) | MAPK1HPGDTYMPTK1 | |
| SCHEMBL29100437 | 0.78 | KMT2A (0.36) | — | |
| SCHEMBL24052575 | 0.78 | TK1 (0.55) | MAPK1HPGDTK1 | |
| SCHEMBL22440027 | 0.77 | MAPK1 (0.39) | MAPK1HPGDTYMPTK1 | |
| SCHEMBL16914966 | 0.76 | MAPK1 (0.38) | MAPK1HPGDTYMPTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039583-B | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2025-03-11 | — | — | CN | claimed |
| CN-119039583-A | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2024-11-29 | — | — | CN | claimed |
| CN-114053248-B | Nucleic acid and small molecule drug co-delivery nano-preparation for regulating tumor metabolism and preparation method thereof | 复旦大学 | 2023-10-20 | — | — | CN | claimed |
| EP-1062383-A4 | ELECTROLYTE AND TIN-SILVER ELECTROPLATING PROCESS | LEARONAL INC (US) | 2002-08-14 | — | — | EP | claimed |
| US-6210556-B1 | FOR DEPOSITING TIN-RICH TIN-SILVER ALLOYS UPON A SUBSTRATE | LEARONAL, INC. | 2001-04-03 | — | — | US | claimed |
| EP-1062383-A1 | ELECTROLYTE AND TIN-SILVER ELECTROPLATING PROCESS | LeaRonal, Inc. (US) | 2000-12-27 | — | — | EP | claimed |
| WO-1999041433-A1 | ELECTROLYTE AND TIN-SILVER ELECTROPLATING PROCESS | LEARONAL, INC. (US) | 1999-08-19 | — | — | WO | claimed |
| CN-119039583-B | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2025-03-11 | — | — | CN | disclosed |
| CN-119039583-A | Side-chain base biodegradable polyester amide with stereocomplex crystallization performance and enzymatic preparation method thereof | 浙江农林大学 | 2024-11-29 | — | — | CN | disclosed |
| CN-118221661-A | Squaric acid amide fluorescent probe based on thiophenyl quinoline for identifying adenosine triphosphate and preparation method thereof | 常州大学 | 2024-06-21 | — | — | CN | disclosed |
| CN-118146198-A | Squaraine fluorescent probe based on methimazole and preparation method and application thereof | 常州大学 | 2024-06-07 | — | — | CN | disclosed |
| CN-114053248-B | Nucleic acid and small molecule drug co-delivery nano-preparation for regulating tumor metabolism and preparation method thereof | 复旦大学 | 2023-10-20 | — | — | CN | disclosed |
| US-10093674-B2 | Supramolecular nanofibers and hydrogels based on nucleic acids functionalized with nucleobases | BRANDEIS UNIVERSITY (US) | 2018-10-09 | — | — | US | disclosed |
| US-5714606-A | OLIGONUCLEOTIDE HAVING RECEPTOR BINDING SITES; ENZYME INHIBITORS, ANTIINFLAMMATORY AGENTS, MEDICAL DIAGNOSIS | ISIS PHARMACEUTICALS, INC. (US) | 1998-02-03 | — | — | US | disclosed |
| EP-0789707-A1 | AMINO ACID NUCLEIC ACIDS | ICN PHARMACEUTICALS (US) | 1997-08-20 | — | — | EP | disclosed |
| EP-0739335-A4 | PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS INC (US) | 1997-04-02 | — | — | EP | disclosed |
| EP-0739335-A1 | PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-30 | — | — | EP | disclosed |
| WO-1996020212-A2 | PEPTIDE NUCLEIC ACID INCORPORATING A CHIRAL BACKBONE | BUCHARDT, DORTE (DK) | 1996-07-04 | — | — | WO | disclosed |
| WO-1996014330-A1 | AMINO ACID NUCLEIC ACIDS | ICNPHARMACEUTICALS (US) | 1996-05-17 | — | — | WO | disclosed |
| WO-1995018792-A1 | PYRROLIDINE-CONTAINING MONOMERS AND OLIGOMERS | ISIS PHARMACEUTICALS, INC. (US) | 1995-07-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10093674-B2 | Supramolecular nanofibers and hydrogels based on nucleic acids functionalized with nucleobases | PHAX, PCNA, RBM28 | MAPK1 3319/4885HPGD 3354/4885TYMP 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.